Clinical trial
Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
NCT00483600 · Duke University, Other · Withdrawn
Key facts
| NCT number | NCT00483600 |
|---|---|
| Title | Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction |
| Official title | Studies of Fondaparinux in Patients With Renal Dysfunction: PK Study of Fondaparinux in Outpatients With Renal Dysfunction |
| Lead sponsor | Duke University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | fondaparinux |
| Enrollment | 0 |
| Start date | Aug 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | Jun 7, 2007 |
| Last update posted | Jul 29, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: